Dr. Timothy Pluard
Claim this profileSaint Luke's Cancer Institute LLC
Studies Breast Cancer
Studies Tumors
13 reported clinical trials
23 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
HER2 positive
2Tumors
Stage IV
Stage III
MMR positive
Affiliated Hospitals
Clinical Trials Timothy Pluard is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
Disitamab Vedotin + Tucatinib
for Breast Cancer
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer. Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2. This clinical trial uses an experimental drug called disitamab vedotin (DV). Disitamab vedotin is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial uses a drug called tucatinib, which has been approved to treat cancer in the United States and some other countries. This drug is sold under the brand name TUKYSA®. This study will test how safe and how well DV, with or without tucatinib, is for participants with solid tumors. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.
Recruiting1 award Phase 1 & 26 criteria
More about Timothy Pluard
Clinical Trial Related1 year of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Timothy Pluard has experience with
- Tucatinib
- Placebo
- Pembrolizumab
- Ladiratuzumab Vedotin
- Trastuzumab Deruxtecan
- Trastuzumab
Breakdown of trials Timothy Pluard has run
Breast Cancer
Tumors
Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy Pluard specialize in?
Timothy Pluard focuses on Breast Cancer and Tumors. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Timothy Pluard currently recruiting for clinical trials?
Yes, Timothy Pluard is currently recruiting for 3 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Timothy Pluard has studied deeply?
Yes, Timothy Pluard has studied treatments such as Tucatinib, Placebo, Pembrolizumab.
What is the best way to schedule an appointment with Timothy Pluard?
Apply for one of the trials that Timothy Pluard is conducting.
What is the office address of Timothy Pluard?
The office of Timothy Pluard is located at: Saint Luke's Cancer Institute LLC, Kansas City, Missouri 64113 United States. This is the address for their practice at the Saint Luke's Cancer Institute LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.